| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/01/2026 | ±3.1% | -4.9% | under-priced |
| 06/25/2026 | ±3.2% | +1.6% | over-priced |
| 03/31/2026 | ±3.4% | -6.1% | under-priced |
| 01/22/2026 | ±2.3% | -8.1% | under-priced |
| 10/07/2025 | ±1.7% | -3.9% | under-priced |
| 06/26/2025 | ±1.8% | +5.3% | under-priced |
| 03/25/2025 | ±1.8% | -0.1% | over-priced |
| 01/23/2025 | ±2.1% | +2.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.36 | $2.0B | $98M |
| Q2 FY2026 | $0.56 | $1.9B | $150M |
| Q1 FY2026 | $3.77 | $1.9B | $1.0B |
| Q4 FY2025 | — | $1.9B | $227M |
MKC (MKC) reports in 63 days, with the next report estimated for 12/29/2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 4.0% on average — the market has been roughly fair on MKC's earnings risk. Fundamentals into the print: EPS down 57.1% year-over-year, revenue up 17.4%. QuantLogix's live 5-factor engine currently reads MKC as a underweight at 44/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →